NCT06521931 2026-03-02
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1 Completed
Chongqing Peg-Bio Biopharm Co., Ltd.
Zhejiang Cancer Hospital